TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Living Cell Technologies ( (AU:1AI) ) has issued an update.
Algorae Pharmaceuticals Limited has announced a change in the interests of its director, David Hainsworth. The company, which operates in the pharmaceutical industry, focuses on developing innovative medical solutions. The announcement details the allotment of 30,000,000 performance rights to Hainsworth, as approved by shareholders at the recent AGM. This change reflects the company’s commitment to aligning its leadership’s interests with long-term strategic goals, potentially impacting its market positioning and stakeholder relations.
More about Living Cell Technologies
Average Trading Volume: 10,231,180
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$14.34M
For an in-depth examination of 1AI stock, go to TipRanks’ Overview page.